Millions rely on Medicare Part D, but many prescription drugs won't be covered in 2026. See which meds are excluded, why, and ...

Fewer choices may be on the menu again as Medicare patients shop for prescription coverage this fall. The number of available, stand-alone drug plans has fallen for a few years, and that trend will ...

Forbes contributors publish independent expert analyses and insights. Diane Omdahl is a Medicare expert who keeps her readers in the know. “FACT SHEET: Seniors Across the Country Are Saving Millions ...

Medicare Part D reforms under the Inflation Reduction Act will lower drug costs by removing the donut hole and adding a ...

As of January 1, 2025, the Medicare Part D phase, known as the coverage gap or “donut hole,” was eliminated. The donut hole was a phase that occurred when a person’s out-of-pocket costs reached a ...

The Inflation Reduction of Act of 2022 included improvements to Medicare Part D, and some have already been enacted—$35 insulin, no more member cost share in the catastrophic phase of coverage, and ...

Patients with Medicare Part D insurance plans experience uneven and “restrictive” coverage of certain drugs and drug classes ...

This year, OPM allowed FEHB plans to begin offering Part D coverage to Medicare-eligible enrollees. To be included, the Part D plan must provide prescription drug coverage that, when combined with an ...

Editorial Note: Blueprint may earn a commission from affiliate partner links featured here on our site. This commission does not influence our editors' opinions or evaluations. Please view our full ...

Here are two very important questions I ask clients who are over 65, still employed, and considering Medicare enrollment. One: “Is your prescription drug coverage considered to be creditable?” The ...

Medicare Part C is private health insurance that often includes prescription drug coverage. Medicare Part D is for prescription drugs only. Many, or all, of the products featured on this page are from ...

Editor’s note: Richard Hughes is a member of the firm Epstein Becker Green in the Health Care & Life Sciences practice and a former vice president for Moderna. In its passage of the Inflation ...